Cargando…
Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients
Autores principales: | Bazzan, Mario, Montaruli, Barbara, Sciascia, Savino, Cosseddu, Domenico, Norbiato, Claudio, Roccatello, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300200/ https://www.ncbi.nlm.nih.gov/pubmed/32557383 http://dx.doi.org/10.1007/s11739-020-02394-0 |
Ejemplares similares
-
Antiphospholipid Antibodies and Infection: Non Nova Sed Nove
por: Sciascia, Savino, et al.
Publicado: (2021) -
Patient Perspective, Complexities, and Challenges in Managed Care
por: Jan, Saira
Publicado: (2010) -
Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
por: Sanoski, Cynthia A., et al.
Publicado: (2009) -
Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort
por: Roccatello, Dario, et al.
Publicado: (2017) -
Hospital mortality and failure of non-invasive ventilation in COVID-19: looking inside the predictive scores
por: Piazza, Isabelle, et al.
Publicado: (2022)